Literature DB >> 12218410

Effect of basal conditions on the magnitude and dynamics of the blood oxygenation level-dependent fMRI response.

Eric R Cohen1, Kamil Ugurbil, Seong-Gi Kim.   

Abstract

The effect of the basal cerebral blood flow (CBF) on both the magnitude and dynamics of the functional hemodynamic response in humans has not been fully investigated. Thus, the hemodynamic response to visual stimulation was measured using blood oxygenation level-dependent (BOLD) functional magnetic resonance imaging (fMRI) in human subjects in a 7-T magnetic field under different basal conditions: hypocapnia, normocapnia, and hypercapnia. Hypercapnia was induced by inhalation of a 5% carbon dioxide gas mixture and hypocapnia was produced by hyperventilation. As the fMRI baseline signal increased linearly with expired CO2 from hypocapnic to hypercapnic levels, the magnitude of the BOLD response to visual stimulation decreased linearly. Measures of the dynamics of the visually evoked BOLD response (onset time, full-width-at-half-maximum, and time-to-peak) increased linearly with the basal fMRI signal and the end-tidal CO2 level. The basal CBF level, modulated by the arterial partial pressure of CO2, significantly affects both the magnitude and dynamics of the BOLD response induced by neural activity. These results suggest that caution should be exercised when comparing stimulus-induced fMRI responses under different physiologic or pharmacologic states.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12218410     DOI: 10.1097/00004647-200209000-00002

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  158 in total

1.  Regional cerebral blood flow and BOLD responses in conscious and anesthetized rats under basal and hypercapnic conditions: implications for functional MRI studies.

Authors:  Kenneth Sicard; Qiang Shen; Mathew E Brevard; Ross Sullivan; Craig F Ferris; Jean A King; Timothy Q Duong
Journal:  J Cereb Blood Flow Metab       Date:  2003-04       Impact factor: 6.200

2.  Contributions of dynamic venous blood volume versus oxygenation level changes to BOLD fMRI.

Authors:  Xiaopeng Zong; Tae Kim; Seong-Gi Kim
Journal:  Neuroimage       Date:  2012-02-28       Impact factor: 6.556

3.  Progress in understanding functional imaging signals.

Authors:  Seong-Gi Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-25       Impact factor: 11.205

4.  Model assessment and model building in fMRI.

Authors:  Mehrdad Razavi; Thomas J Grabowski; Walter P Vispoel; Patrick Monahan; Sonya Mehta; Brent Eaton; Lizann Bolinger
Journal:  Hum Brain Mapp       Date:  2003-12       Impact factor: 5.038

Review 5.  Imaging Alzheimer's disease.

Authors:  Scott A Small
Journal:  Curr Neurol Neurosci Rep       Date:  2003-09       Impact factor: 5.081

Review 6.  Combining brain imaging with microarray: isolating molecules underlying the physiologic disorders of the brain.

Authors:  Aimee Pierce; Scott A Small
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

7.  Imaging oxygen consumption in forepaw somatosensory stimulation in rats under isoflurane anesthesia.

Authors:  Zhaohui M Liu; Karl F Schmidt; Kenneth M Sicard; Timothy Q Duong
Journal:  Magn Reson Med       Date:  2004-08       Impact factor: 4.668

8.  Medial temporal lobe function and structure in mild cognitive impairment.

Authors:  Bradford C Dickerson; David H Salat; Julianna F Bates; Monika Atiya; Ronald J Killiany; Douglas N Greve; Anders M Dale; Chantal E Stern; Deborah Blacker; Marilyn S Albert; Reisa A Sperling
Journal:  Ann Neurol       Date:  2004-07       Impact factor: 10.422

Review 9.  Biophysical and physiological origins of blood oxygenation level-dependent fMRI signals.

Authors:  Seong-Gi Kim; Seiji Ogawa
Journal:  J Cereb Blood Flow Metab       Date:  2012-03-07       Impact factor: 6.200

Review 10.  The physiology of developmental changes in BOLD functional imaging signals.

Authors:  Julia J Harris; Clare Reynell; David Attwell
Journal:  Dev Cogn Neurosci       Date:  2011-04-27       Impact factor: 6.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.